EC-18 for Oral Mucositis in Patients With Concomitant Chemoirradiation
Public ClinicalTrials.gov record NCT03200340. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate EC-18 for Oral Mucositis in Patients With Concomitant Chemoirradiation for Cancers of the Mouth, Oropharynx, Hypopharynx and Nasopharynx
Study identification
- NCT ID
- NCT03200340
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Enzychem Lifesciences Corporation
- Industry
- Enrollment
- 105 participants
Conditions and interventions
Conditions
Interventions
- EC-18 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2, 2018
- Primary completion
- May 13, 2021
- Completion
- May 13, 2021
- Last update posted
- Jul 26, 2023
2018 – 2021
United States locations
- U.S. sites
- 20
- U.S. states
- 14
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Veterans Affairs Long Beach Health Care System | Long Beach | California | 90822 | — |
| UCLA Jonsson Comprehensive Cancer Center | Los Angeles | California | 90095 | — |
| Miami Cancer Institute | Miami | Florida | 33176 | — |
| Mount Sinai Comprehensive Cancer Center | Miami Beach | Florida | 33140 | — |
| Winship Cancer Institute of Emory University | Atlanta | Georgia | 30322 | — |
| NorthShore University HealthSystem | Evanston | Illinois | 60201 | — |
| Southern Illinois University School of Medicine | Springfield | Illinois | 62702 | — |
| Cancer Center of Kansas | Wichita | Kansas | 67214 | — |
| University of Kentucky, Chandler Medical Center, CCTS | Lexington | Kentucky | 40536 | — |
| Greater Baltimore Medical Center | Baltimore | Maryland | 21204 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110-1010 | — |
| Mount Sinai - Union Square | New York | New York | 10003 | — |
| University of Oklahoma Health Sciences Center | Oklahoma City | Oklahoma | 73104 | — |
| Oregon Health and Science University | Portland | Oregon | 97239 | — |
| VA Portland HealthCare System | Portland | Oregon | 97239 | — |
| St. Luke's Cancer Center - Anderson Campus | Easton | Pennsylvania | 18045 | — |
| Hope Cancer Center of East Texas | Tyler | Texas | 75701 | — |
| Baylor Scott & White Medical Center - Hillcrest | Waco | Texas | 76712 | — |
| MultiCare Institute for Research and Innovation | Spokane | Washington | 98405 | — |
| MultiCare Institute for Research and Innovation | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03200340, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 26, 2023 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03200340 live on ClinicalTrials.gov.